Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
Clinical Immunology (Orlando, Fla.)|September 2, 2022
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaXiaoxuan Wang, Yuheng Hong, Shen Meng, et al.British Journal of Haematology|October 19, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNASicong Zhang, Tingting Zhang, Hengqi Liu, et al.Oncology Letters|August 25, 2020
Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphomaLeiyuan Chen, Yutian Kan, Xinyuan Wang, et al.Clinical Immunology (Orlando, Fla.)|May 7, 2023
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphomaYaxiao Lu, Yang Li, Jingwei Yu, et al.Journal of Cellular Physiology|April 26, 2018
ROS-Autophagy pathway mediates monocytes-human umbilical vein endothelial cells adhesion induced by apelin-13Meiqing Liu, Hening Li, Qun Zhou, et al.Journal of Advanced Research|October 11, 2025
Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responsesQi Jin, Lanfang Li, Peng Qu, et al.Frontiers in Oncology|August 2, 2021
An Immune-Clinical Prognostic Index (ICPI) for Patients With <i>De Novo</i> Follicular Lymphoma Treated With R-CHOP/CHOP ChemotherapyYaxiao Lu, Jingwei Yu, Wenchen Gong, et al.Oncotarget|May 6, 2016
Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cellsLing Dong, Huijuan Lv, Wei Li, et al.Hematological Oncology|April 3, 2022
A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphomaHuijuan Lv, Yue Fei, Wei Li, et al.Nucleic Acids Research|January 31, 2020
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translationTao Liu, Qinglv Wei, Jing Jin, et al.Pageof 19